Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis

類似資料

• Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis
  著者:: Naidoo, Anushka, 等
  出版事項: (2019)
• Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB
  著者:: Naidoo, Anushka, 等
  出版事項: (2017)
• A review of moxifloxacin for the treatment of drug-susceptible tuberculosis
  著者:: Naidoo, Anushka, 等
  出版事項: (2017)
• Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
  著者:: Naidoo, Anushka, 等
  出版事項: (2017)
• The effect of timing of initiation of ART on loss to follow up in HIV-TB co infected patients in South Africa: An open label randomized controlled trial
  著者:: Yende-Zuma, Nonhlanhla, 等
  出版事項: (2016)